SCHEMBL5090285

SCHEMBL5090285

NN(C(=O)OCc1ccccc1Cl)c1ccc(OCc2ccc(F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 9/20 0.46
PARP10 Q53GL7 1/20 0.46
NR4A2 P43354 2/20 0.45
MAOA P21397 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
S1PR5 Q9H228 1/20 0.42
TP53 P04637 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090872 0.86 NR4A2 (0.53) MAOBPARP10NR4A2HDAC1HDAC2
SCHEMBL5090749 0.81 MAOB (0.51) MAOBPARP10NR4A2MAOAHDAC1
SCHEMBL5089215 0.81 MAOB (0.51) MAOBPARP10NR4A2MAOAHDAC1
SCHEMBL5090818 0.80 MAOB (0.53) MAOBPARP10NR4A2MAOACA12
SCHEMBL5095835 0.80 MAOB (0.50) MAOBPARP10NR4A2MAOAHDAC1
SCHEMBL5096558 0.79 MAOB (0.52) MAOBPARP10NR4A2CA12CA1
SCHEMBL5090783 0.79 MAOB (0.49) MAOBPARP10NR4A2MAOAHDAC1
SCHEMBL5089208 0.78 MAOB (0.51) MAOBPARP10NR4A2MAOACA12
SCHEMBL5090765 0.78 MAOB (0.56) MAOBPARP10NR4A2MAOAHDAC1
SCHEMBL5090889 0.77 MAOB (0.50) MAOBPARP10NR4A2MAOAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 MAOB 808/4885PARP10 2373/4885NR4A2 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.